CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
35.26
13-February-25 15:45:00
15 minutes delayed
Stocks
+0.05
+0.14%
Today's range
35.07 - 35.85
ISIN
N/A
Source
NASDAQ
-
10 Feb 2025 15:44:27 By Nasdaq GlobeNewswire
-
06 Feb 2025 15:35:20 By Nasdaq GlobeNewswire
-
10 Jan 2025 16:15:15 By Nasdaq GlobeNewswire
-
10 Jan 2025 06:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
06 Jan 2025 07:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer
16 Dec 2024 07:00:00 By Nasdaq GlobeNewswire
-
10 Dec 2024 19:44:38 By Nasdaq GlobeNewswire
-
09 Dec 2024 07:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
15 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
14 Nov 2024 15:05:00 By Nasdaq GlobeNewswire
-
12 Nov 2024 15:07:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
12 Nov 2024 15:05:00 By Nasdaq GlobeNewswire
-
11 Nov 2024 15:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024
16 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
10 Oct 2024 15:40:28 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
08 Oct 2024 22:55:11 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
08 Oct 2024 15:01:51 By Nasdaq GlobeNewswire
-
Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
26 Sep 2024 15:05:00 By Nasdaq GlobeNewswire
-
10 Sep 2024 15:40:25 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences
29 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >